Home Molecular Dx Assay Development

Assay Development

Latest
Assay Development

PerkinElmer Genomics, U. of Iowa Develop FSHD Assay Based on Bionano’s...

DNA sequencing
Assay Development

POC Platform Developer GNA Biosolutions Closes $13.5M Series C

ArcherDx has expanded further into assay development with its acquisition of Baby Genes. Through the purchase
Assay Development

ArcherDx Expands Further into Assay Development by Acquiring Baby Genes

ersonal Genome Diagnostics (PGDx) said today that its 500+ gene pan-cancer tumor profiling tissue assay is being used by Merck & Co. in a Phase II clinical trial designed to assess patient response to a dual biomarker-directed precision oncology combination therapy in patients with previously untreated advanced non-small cell lung cancer (NSCLC).
Assay Development

Merck Using PGDx Pan-Cancer Tissue Assay in Combination Therapy Trial

Biocept will evaluate the clinical utility and cost effectiveness of using Biocept's Target Selector testing in patients diagnosed with non-small cell lung cancer (NSCLC)
Assay Development

Biocept to Study Clinical Utility, Cost Effectiveness of Assays in NSCLC...

Vela Diagnostics has expanded into microbiology with its acquisition of Great Basin Scientific
Assay Development

Vela Diagnostics Expands into Microbiology with Great Basin Scientific Acquisition

Fluidigm and Genomenon plan to create a joint panel design offering intended to help researchers accelerate the design of disease-specific next-generation sequencing
Assay Development

Fluidigm Partnering with Genomenon to Offer Genomic Panel Design Services

GenomeDx Biosciences will use its Decipher Prostate Cancer Classifier tests
Assay Development

Janssen Pharmaceuticals to Use GenomeDx Prostate Cancer Tests, Database

ArcherDX said its Archer Immunoverse and VariantPlex NGS assays will be used by Ambry toward offering its biopharma customers large-scale immune repertoire analysis and chimeric antigen T-cell receptor (CAR-T) manufacturing characterization and pharmacodynamics. [royaltystockphoto/Getty Images]
Assay Development

ArcherDX, Ambry to Offer Immune Repertoire, CAR-T-Related Sequencing Services

Caris Life Sciences has filed a federal lawsuit accusing Foundation Medicine of infringing on five patents in the development of three cancer assays. Foundation Medicine says it will "vigorously defend the allegations made." [Source: © benqook/Fotolia]
Assay Development

Caris Accuses Foundation Medicine of Patent Infringement in Developing Cancer Assays

Load more

Featured

High Speed Cell Sorter Allows Genome-Scale Studies of Complex Phenotypes

High Speed Cell Sorter Allows Genome-Scale Studies of Complex Phenotypes

Immunotherapy Can Induce Remission in Young Children with Peanut Allergy

Immunotherapy Can Induce Remission in Young Children with Peanut Allergy

Gene Therapy for Severe Form of Epilepsy Shows Promise

Gene Therapy for Severe Form of Epilepsy Shows Promise

Tau Interactome Map Suggests How Mutated Brain Protein Spreads

Tau Interactome Map Suggests How Mutated Brain Protein Spreads

New Products

View All
Load more
Copyright © 2022 Genetic Engineering & Biotechnology News. All Rights Reserved.